Results 131 to 140 of about 34,537 (182)

Integrating HIV and Stimulant-Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV Care. [PDF]

Clin Infect Dis
Appa A, Steiner G, Baral S, Riley E, Suchman L, Roberts K, Knight K, Murphy M, Chamie G, Shoptaw S, Coffin PO, Gandhi M.   +11 more
europepmc   +1 more source

Brief Report: Postpartum Maternal Monitoring for Renal Safety Related to Tenofovir Exposure During Breastfeeding in the PROMISE 1077BF Randomized Trial. [PDF]

J Acquir Immune Defic Syndr
Baltrusaitis K, Tierney C, Fowler MG, Owor M, Nematadzira TG, Nyakudya L, Cassim H, de Jager J, George K, Heckman B, Knowles K, Browning R, Siberry GK, Taha TE, Stranix-Chibanda L, PROMISE P1084s Study Team.   +15 more
europepmc   +1 more source

Antiretroviral therapy persistence among treatment-experienced people with HIV and mental health disorders and/or substance use disorders in the USA (2017-2024): a retrospective cohort study. [PDF]

J Comp Eff Res
Mordi U, Christoph MJ, Chastek B, Lim T, Neia Prata Menezes, Majethia S, Le LB, Cohen J.   +7 more
europepmc   +1 more source

Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B. [PDF]

JHEP Rep
Holmberg M, Niehrs A, Dalgard O, Berhe N, Desalegn H, Aleman S, Weis N, Stenstad T, Heggelund L, Samuelsen E, Karlsen LN, Lindahl K, Kleppa E, Winckelmann AA, Brugger-Synnes P, Simonsen HE, Svendsen J, Björkström NK, Reikvam DH, Johannessen A.   +19 more
europepmc   +1 more source

Antiretroviral therapy switch among Medicare beneficiaries with HIV. [PDF]

J Manag Care Spec Pharm
Christoph MJ, Mordi U, Li S, Guo H, Gong T, Lim T, Park S, Zachry W, Tien PC.   +8 more
europepmc   +1 more source

Comparable efficacy of bictegravir/emtricitabine/tenofovir alafenamide and doravirine/lamivudine/tenofovir disoproxil fumarate in therapy-naive Human Immunodeficiency Virus adults with very high baseline viraemia. [PDF]

J Med Microbiol
Calza L, Giglia M, Rigamonti C, Zuppiroli A, Marzolla D, Bon I, Viale P.   +6 more
europepmc   +1 more source

R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation. [PDF]

S Afr J Infect Dis
Naidoo S.
europepmc   +1 more source

Effectiveness of Pre-exposure Prophylaxis (PrEP) in the Prevention of Human Immunodeficiency Virus (HIV): A Systematic Review of Randomized Controlled Trials With Narrative Synthesis. [PDF]

Cureus
Sharma B, Sharma O.
europepmc   +1 more source

Turning back time: a comprehensive list of interventions that decrease next-generation epigenetic aging clocks in humans. [PDF]

Front Genet
Johnson AA, Sinclair DA.
europepmc   +1 more source

In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort. [PDF]

Clin Infect Dis
Mann SC, Lykins D, Coyle RP, Witt MD, Kim EY, Macatangay B, Brown TT, Dionne JA, Alcaide M, Lahiri CD, Ramirez C, Dumond JB, D'Souza G, Cohen MH, Wilson TE, Kassaye S, Tien PC, Adedimeji AA, Ellison L, Brooks KM, Bushman LR, Anderson PL, MaWhinney S.   +22 more
europepmc   +1 more source